Skip to main content

Non-Small Cell Lung Cancer Clinical Trials

NSCLC Clinical Trials Redefining Possibilities in Care and Survival.

Enroll Now

NSCLC Clinical Trials in Oklahoma City, OK

Non-Small Cell Lung Cancer (NSCLC) is the most common type of lung cancer, accounting for approximately 85% of all lung cancer cases. It typically grows and spreads more slowly than Small Cell Lung Cancer, allowing for different treatment approaches. However, NSCLC still presents significant challenges and remains a leading cause of cancer-related mortality worldwide.

In the United States, survival rates for NSCLC vary based on factors such as gender and the extent of cancer spread at diagnosis. Women diagnosed with NSCLC have a 5-year relative survival rate of 33%, while for men, it is 23%. However, localized NSCLC, where the cancer has not spread beyond the lung. In such cases, the overall 5-year relative survival rate stands at 65%.

*Participation in the Clinical Trial is completely free of cost and is your choice.

*To participate, fill out the form, and someone from our research staff will call you to determine your eligibility for the Clinical Research Study.

NSCLC Clinical Trials: Advancing Care Through Your Participation

Non-small cell lung cancer (NSCLC) is a type of lung cancer that includes different subtypes such as adencarcinoma, squamous cell carcinoma, and large cell carcinoma.

Efforts to improve early detection methods and lung cancer treatment outcomes are ongoing. The Hightower clinical trial is one initiative exploring new approaches to tackle NSCLC. We are evaluating new lung cancer medication and immunotherapy techniques to enhance treatment effectiveness. Furthermore, our research extends to investigating new biomarkers aimed at streamlining cancer screening processes.

*All study procedures and study-related treatment, including the investigational drug, are free of cost, and insurance is not required to participate.

*The study doctor will take you through every step of the Clinical Trial before you decide to participate and will answer any questions you have about the study treatment.

What to Expect

If you decide to participate in the Non-Small Cell Lung Cancer Clinical Trials, by filling out the form above, someone from the study team will contact you to determine your eligibility. The team will go over the study details with you to see if you meet the eligibility criteria for the NSCLC Clinical Trials.

You will be invited to the study location for screening if you meet the criteria. The study site will be within a 50-mile radius of your current location. The study doctors will advise you on the duration of the clinical trials for non-small cell lung cancer and the implications of your involvement in this research study. We invite you to ask as many questions as you like. After thoroughly explaining everything to the participants, they will be requested to sign an Informed Consent Form. We value transparency between our participants and investigators

*Study-related care is offered at no charge. Expert physicians and healthcare professionals conduct thorough physical exams and assessments.*


18 Years and Older


Male & Female


Non-Small Cell Lung Cancer

Current Status


Non-Small Cell Lung Cancer (NSCLC): The Silent Threat

Non-Small Cell Lung Cancer (NSCLC) is a formidable adversary, silently progressing within the lungs until symptoms manifest.

As the most prevalent form of lung cancer, NSCLC presents challenges for patients and healthcare providers. Individuals with NSCLC often experience a gradual onset of symptoms,

  • persistent cough
  • chest pain
  • shortness of breath.

The impact of NSCLC extends beyond physical symptoms, often taking a toll on patients’ emotional well-being and quality of life.

NSCLC predominantly affects the lung tissue, with tumors forming in the large airways. As the disease progresses, it can spread to nearby lymph nodes and other organs, further complicating treatment and prognosis.

High Tower is committed to advancing the fight against NSCLC through innovative research, personalized lung cancer treatment, and unwavering support for patients and their families.

Frequently Asked Questions

Am I eligible to participate in an NSCLC clinical trial?

It will depend on factors like your age, overall health, type and stage of NSCLC, and prior treatments received.

What are the potential risks and benefits of participating in an NSCLC clinical trial?

They may involve unknown side effects or require more frequent doctor visits. You will be informed of all the risks before you sign the consent form.

What happens if I am chosen to participate in an NSCLC clinical trial?

You can expect a detailed informed consent process explaining the trial protocol, potential side effects, and your rights as a participant.